Form 4 for PFE Pfizer
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-31 · accession 0001225208-22-007553 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-01 | 2022-05-31 | PFE | Denton David M | CFO, EVP | A - Grant | $0.00 | +61.3K | 62.2K | +6,885% | $0 |
| DM | 2022-06-01 | 2022-05-31 | PFE | Denton David M | CFO, EVP | A - Grant | $0.00 | +151.0K | 70.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | A | A | 61,275 | $0.00 | 62,165 | D | — | — | (F1) The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. |
| 2 | Derivative | Stock Appreciation Rights | 2022-05-31 | A | A | 80,703 | $0.00 | 80,703 | D | $53.04 · 2027-05-31 to 2027-05-31 | 80,703 Common Stock | (F2) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
| 3 | Derivative | Stock Appreciation Rights | 2022-05-31 | A | A | 70,313 | $0.00 | 70,313 | D | $53.04 · 2029-05-31 to 2029-05-31 | 70,313 Common Stock | (F3) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |